Biological 3d printing
What is 3D Bioprinting? | Bioprinting Explained
“3D Bioprinting” or “bioprinting” is a form of additive manufacturing that uses cells and biomaterials instead of traditional metals and plastics to create 3D constructs that are functional 3D tissues. These biomaterials are called bioinks, and they mimic the composition of our tissues. Bioprinting can be applied to a variety of areas including but not limited to regenerative medicine, drug discovery and development, and 3D cell culture.A 3D construct bioprinted on an Allevi by 3D Systems bioprinter
Bioprinted structures, such as organs-on-chips, can be used to study functions of a human body outside the body, in 3D. The geometry of a 3D bioprinted structure is more similar to that of a naturally occurring biological system than an in vitro 2D model. Structural similarity can in turn lead to functional results that are more physiologically relevant. No other technology enables the level of geometric complexity in engineering tissues that 3D bioprinting enables. That is why this technology has the potential to completely change the way we treat diseases – by replacing animal testing and ending the organ transplant waiting list.
How does 3D bioprinting work?
3D bioprinting starts with a model of a structure, which is recreated layer-by-layer out of a bioink either mixed with living cells, or seeded with cells after the print is complete. These starting models can come from anywhere – a CT or MRI scan, a computer generated design (CAD) program, or a file downloaded from the internet.
That 3D model file is then fed into a slicer – a specialized kind of computer program which analyzes the geometry of the model and generates a series of thin layers, or slices, which form the shape of the original model when stacked vertically. Cura and slic3r are examples of slicers commonly used in 3D printing. Allevi also has a specialized slicer, optimized specifically for bioprinting, built into our Allevi Bioprint software.
Once a model is sliced, the slices are transformed into path data, stored as a G-code file, which can be sent to a 3D bioprinter for printing. The bioprinter follows instructions in the G-code file in order, including instructions to control for temperature of the extruders, extrusion pressure, bed plate temperature, crosslinking intensity and frequency, and, of course, the 3D movement path generated by the slicer. Once all of the G-code commands are completed, the print is done and can be cultured or seeded with cells as part of a biostudy.
Why is bioprinting important?
Over 120,000 people in the US alone are on waiting lists for organs, and others experience chronic problems due to the long-term damaging effects of post-transplant immunosuppression. There is a large and growing need for an alternative to the organ transplant waiting list. The scientific community has already succeeded in bringing together multidisciplinary teams of researchers, physicians, and engineers to take on the biggest challenges to human health, and 3D bioprinting is an exciting new tool with the potential to eliminate the organ transplant waiting list.
For pharmaceutical development, 3D bioprinting offers a means of testing drugs faster, at a lower cost, and with better biological relevance to humans than animal testing. In the biomedical devices field, 3D bioprinting has enabled new developments such as sugar stents to help surgeons join veins with fewer complications, and systems for improved drug delivery, among others.
As bioprinting evolves, it will become possible to use a patient’s own cells to 3D print skin and bone grafts, organ patches, and even full replacement organs. Personalized and regenerative medicine continue to grow in popularity, and 3D bioprinting will give doctors and researchers the tools to better target treatments and improve patient outcomes.
Bioprinting 101 – Allevi
3D Bioprinting – Wikipedia
3D Bioprinting of Living Tissues – Wyss Institute, Harvard
Bioprinting – NIH Director’s Blog
What is 3D bioprinting? | 3D Bioprinting technologyThe history of 3D bioprinting – where it all began?
3D bioprinting is evolving rapidly since researchers have innovated and driven the field forward. However, as a technology, 3D printing is not a new invention. The first steps in 3D printing were taken in 1980s, when in 1984 Charles Hull filed a patent for the first commercial 3D printing technology. This has been a symbol of the birth of 3D printing, and it created the base for 3D bioprinting as well. Bioprinting came into picture in 1988, when Robert J. Klebe used inkjet printer for printing cells.1 After these first steps, the field has constantly evolved, and new methods and techniques have been discovered. The countless possibilities and opportunities to create something ground-breaking keep intriguing scientists, and thus bioprinting has become a popular technology.
What is 3D bioprinting and how does bioprinting work?
3D bioprinting is an additive manufacturing process that uses bioinks to print living cells developing structures layer-by-layer which imitate the behavior and structures of natural tissues. Bioinks, that are used as a material in bioprinting, are made of natural or synthetic biomaterials that can be mixed with living cells.
The technology and bioprinted structures enable researchers to study functions of the human body in vitro. 3D bioprinted structures are more biologically relevant compared to in vitro studies performed in 2D.
Mostly, 3D bioprinting can be used for several biological applications in the fields of tissue engineering, bioengineering and materials science. The technology is also increasingly used for pharmaceutical development and drug validation. Clinical settings such as 3D printed skin and bone grafts, implants and even full 3D printed organs are currently at the center of bioprinting research.
3D bioprinting of tissues and organs for regenerative medicine
Three-dimensional bioprinting plays an important role in tissue engineering which aims to fabricate functional tissue for applications in regenerative medicine and drug testing. Tissue regeneration and reconstruction could enable the possibility to repair or replace damaged tissues and organs.
Advantages and disadvantages of 3D bioprinting
Advantages of 3D bioprinting
- Allows mimicking the real structure of desired tissue/organ etc.
- Possibility to revolutionize future medical treatment capabilities
- Possible creation of patient-specific and organ-specific treatments
- Effects of drugs can be examined more accurately
- Decreases animal testing
- Biocompatibility with human cells and tissues
- Automating complex processes
- Consistency, less human errors
Disadvantages of 3D bioprinting
- Pricing, expensive technology
- Maintaining cell environment can be difficult
- Ethical concerns
- Energy consumption
3D bioprinting bioinks
Bioinks are used as the base material when bioprinting tissue-, organ-, or bone-like structures with bioprinters. 3D bioinks can be cell-laden, scaffold-free, or cell-free, like GrowInk™, which is an easily customizable hydrogel-based bioink made of nanofibrillar cellulose and water.
GrowInk’s cell-free form allows it to be tailored well to fit multiple research areas and purposes.
Choosing the right composition of bioink, and the bioink density can affect the cell viability and cell density, hence, selecting the most suitable bioink for each research purpose is essential.
Read more about GrowInk
3D printers and 3D bioprinters are similar to each other, but 3D printers are designed to print solid materials, where 3D bioprinters are designed to print liquid or gel. 3D bioprinters are also designed to handle sensitive material that contain living cells, without creating too much damage on the end result. Bioprinters can be inkjet based, laser assisted, or extrusion based. Each printer type has its pros and cons when it comes to cost, cell viability, cell density, resolution, and so on. Bioprinters’ compatibility with bioinks also varies, and therefore it is important to ensure the bioprinter and bioink work well together.
Commercially available cell printers
3D Bioprinting solutions – hints and tips for bioprinting
- Select the most suitable bioink for your research purpose and ensure the bioink you are using is compatible with the selected printing method and cell types
- Know what you are printing – create a new digital 3D model of the structure you want to print or get a license for an existing model
- Use fresh or new printer tips that are specifically fitted for your system
- Test different nozzle/needle sizes, printing speeds, and layer heights and optimize them based on the results
- Make sure the working temperature is suitable for the printer and the used materials
- Set an optimal printing pressure. A bit higher pressure is usually needed when printing with cells
Check out hints and tips when using GrowInk
Future of 3D bioprinting
The rapid development of technology can also be seen in the advancement of bioprinting. Three-dimensional bioprinting technology has the potential to solve numerous problems in areas such as healthcare. Functioning bladders, which have been grown using bioprinted tissue from patients’ own cells have already been transplanted into human body successfully2,3. Researchers are constantly researching the possibility of bioprinting other functioning organs.
One future scenario of 3D bioprinting could be that no-more organ donors are needed, as personalized human organs can be printed using the patients’ own cells or stem cells as a base. This technology can be revolutionizing in preventing and fixing diseases. Eventually, it is hoped that bioprinting technology will enhance medical care and make it more efficient.
Applications of 3D bioprinting
3D printing of GrowInk™-N and GrowInk™-T with Poietis NGB-R™ bioprinter
High-throughput production of GrowInk™-T models by drop-on-demand 3D bioprinting
Wang, Q. , et al., (2021). Rheological and Printability Assessments on Biomaterial Inks of Nanocellulose/Photo-Crosslinkable Biopolymer in Light-Aided 3D Printing. Available from: https://doi.org/10.3389/fceng.2021.723429.
Fonseca, A.C., et al., (2020). Emulating Human Tissues and Organs: A Bioprinting Perspective Toward Personalized Medicine. Chemical Reviews. Available from: https://doi.org/10.1021/acs.chemrev.0c00342.
Wang, X., Q. Wang, and C. Xu, (2020). Nanocellulose-Based Inks for 3D Bioprinting: Key Aspects in Research Development and Challenging Perspectives in Applications-A Mini Review. Bioengineering (Basel), 7(2). Available from: https://doi.org/10.3390/bioengineering7020040
Yadav, C., et al., (2020). Plant-based nanocellulose: A review of routine and recent preparation methods with current progress in its applications as rheology modifier and 3D bioprinting. International Journal of Biological Macromolecules. Available from: http://www.sciencedirect.com/science/article/pii/S0141813020349631.
Ashammakhi, N., et al., (2019). Bioinks and bioprinting technologies to make heterogeneous and biomimetic tissue constructs. Materials Today Bio, 1: p. 100008. Available from: https://www.sciencedirect.com/science/article/pii/S2590006419300146.
Di Marzio, N., et al., (2020). Bio-Fabrication: Convergence of 3D Bioprinting and Nano-Biomaterials in Tissue Engineering and Regenerative Medicine. Frontiers in Bioengineering and Biotechnology, 8(326). Available from: https://www.frontiersin.org/article/10.3389/fbioe.2020.00326.
Jovic, T.H., et al., (2019). Plant-Derived Biomaterials: A Review of 3D Bioprinting and Biomedical Applications. Frontiers in Mechanical Engineering, 5(19). Available from: https://www.frontiersin.org/article/10.3389/fmech.2019.00019.
1Gu, Z., Fu, J., Lin, H. and He, Y., 2020. Development of 3D bioprinting: From printing methods to biomedical applications. Asian Journal of Pharmaceutical Sciences, 15(5), pp.529-557.
2Atala, A., Bauer, S., Soker, S., Yoo, J. and Retik, A., 2006. Tissue-engineered autologous bladders for patients needing cystoplasty. The Lancet, 367(9518), pp.1241-1246.
3 Belton, P., 2018. 'A new bladder made from my cells gave me my life back'. BBC, [online] Available at: <https://www.bbc.com/news/business-45470799> [Accessed 6 August 2021].
Organ printing: how 3D bioprinting technology has advanced and what is hindering its development In research centers and hospitals around the world, advances in 3D printing and bioprinting are providing new opportunities for human treatment and scientific research. In the coming decades, bioprinting could be the next major milestone in healthcare and personalized medicine.
Let's talk about bioprinting technology, the latest advances in the industry and the limitations that professionals face.
How a 3D printer works
Traditional printers, like the one you have at home or office, work in two dimensions. They can print text or images on a flat surface (usually paper) using the x (horizontal) and y (vertical) dimensions. 3D printers add another dimension - depth (z). During the printing process, the printer heads can move up and down, left and right, back and forth, but instead of delivering ink to paper, they distribute various materials - polymers, metal, ceramics and even chocolate - until the "print" of a holistic, voluminous object , layer by layer in a process known as "additive manufacturing".
To create a 3D object, you need a blueprint for it, a digital file created with modeling software. After its creation, the computer-generated model is sent to the printer. Your chosen material is loaded into the machine and ready to be heated to easily flow out of the printer nozzle. As the printer reads the plan, its head moves, depositing successive layers of the selected material to create the final product.
As each layer is printed, it is solidified either by cooling or by mixing two different solutions delivered by the printer head. The new layers precisely lay down on the previous ones to make a stable, cohesive element. In this way, you can create almost any shape, including a moving one.
3D printing allows you to create objects with geometric structures that would be difficult or impossible to make in other ways. A wide range of products are already being created using 3D printers, including jewelry, clothing, toys, and high-end industrial products. Even a 10-year-old Moscow schoolboy has learned how to work with a 3D printer: he prints 3D figures to order and sells them through Instagram.
How a bioprinter works
Bioprinters work in much the same way as 3D printers, with one key difference - they deposit layers of biomaterial, which can include living cells, to create complex structures such as blood vessels or skin tissue.
Living cells? Where do they get them? Every tissue in the body is made up of different types of cells. The required cells (kidney, skin, and so on) are taken from the patient and then cultured until there are enough of them to create "bio-ink" that is loaded into the printer. This is not always possible, therefore, for some tissues, stem cells are taken that are capable of becoming any cell in the body (organism), or, for example, porcine collagen protein, seaweed and others.
Often used in bioprinting is chitosan, a polysaccharide obtained from the external skeleton of mollusks (eg shrimp) or by fermenting fungi. This material has high biocompatibility and antibacterial properties. Its disadvantage is the low rate of gelation. Another popular material is a polysaccharide isolated from seaweed called agarose. Its advantages are high stability and the possibility of non-toxic cross-linking during research. However, this biomaterial does not decompose and has poor cell adhesion (the ability of cells to stick together with each other and with other substrates).
Collagen, a primary structural protein found in the skin and other connective tissues, has a high biological significance. It is the most abundant protein in mammals and a major component of connective tissue. Its disadvantages for bioprinting include the property of acid solubility. More information about biomaterials can be found here.
Based on computer designs and models, often scans and MRIs taken directly from the patient, the printer heads place the cells exactly where they are needed and within a few hours an organic object is built from a large number of very thin layers.
Organovo bioprinter creates tissues that mimic the structure and composition of various human organs
Scaffolding for ear or nose replacement at Wake Forest University in Winston-Salem, North Carolina
Source: CBS News
Computer displays an image of a "scaffold" for the human ear, created in the laboratory of Wake Forest University in Winston-Salem, North Carolina
Source: CBS News
Usually more than just cells are needed, so most bioprinters also supply some kind of organic or synthetic "glue" - a soluble gel or collagen scaffold to which cells can attach and grow. This helps them form and stabilize in the correct shape. Surprisingly, some cells can take the correct position on their own without any "scaffolding". How do they know where to go? How do embryonic cells develop in the uterus, or does adult tissue move to repair damage? Same here.
Universities, researchers and private companies around the world are involved in the development of bioprinting technologies. Let's take a look at some of the amazing things they are working on.
Bioprinting in Russia
3D Bioprinting Solutions is a biotechnology research laboratory founded by medical company INVITRO. The activity of the laboratory is the development and production of bioprinters and materials in the field of three-dimensional bioprinting and scientific research. August 23, 20193D Bioprinting Solutions laboratory sent a new batch of cuvettes to the ISS to continue experiments on bioprinting in space, which began in 2018. This was reported in the press center of the laboratory. This time it is planned to use organic and inorganic components to assemble bone tissue on the world's first space bioprinter Organ.Aut.
Symposium "Biofabrication in Space"
Organ.Aut magnetic bioprinter
The astronauts will also grow protein crystals and experiment with printing biofilms of bacteria to study their behavior in zero gravity. Russian scientists expect to receive unique scientific data that can be applied in the development of new drugs.
Scientific director of 3D Bioprinting Solutions and leading researcher of the Institute of Regenerative Medicine, Candidate of Medical Sciences Vladimir Mironov, in his speech at the Department of Anatomy of Sechenov University on September 2, noted: “Living cells, tissues and human organs will be synthesized already in the current century. To do this, morphological sciences, such as microscopic anatomy and histology, must be digitized or digitalized, that is, digitized and made available for computer programs of robotic bioprinters, since without digital models it is impossible to print human tissues and organs. ”
Bioprinting around the world
Every year, millions of people around the world need bone grafting. Modern bone grafts often use cement-based synthetic material in combination with the patient's own bone. However, the use of these materials has a number of limitations - some transplants caused rejection and inflammatory processes in patients. Reproduction of the natural bone-cartilage "interface" has also been problematic.
However, a team at Swansea University in 2014 developed a bioprinting technology that allows the creation of an artificial bone prosthesis in the exact shape of the desired bone, using a biocompatible material that is both durable and regenerative. At the same time, scientists from the University of Nottingham in England were working on similar studies.
It takes about two hours to print a small bone. Therefore, surgeons can do it right in the operating room. This part of the bone is then covered with adult stem cells that can develop into almost any other type of cell. This is combined with bio-ink from the printer, a combination of polylactic acid (which provides mechanical strength to bone) and alginate, a gel-like substance that serves as a shock-absorbing material for cells. The end product is then implanted into the body, where it will completely disappear within about three months and be replaced by new bone.
Researchers hope that in the future, bioprinted bones can be created with sufficient reliability to support complex spinal reconstruction, and that the bone material will be further improved to increase its compatibility with cartilage cells.
Source: ETH Zurich
Successful 3D printing of human cartilage may soon completely replace artificial implants for people in need of reconstructive surgery. Back in 2015, scientists in Zurich developed technology that would allow hospitals to print a full-size human nose implant in less than 20 minutes. They believe that any cartilage implant can be made using their technique.
Researcher Matti Kesti described the technology as follows:
“A serious car accident can cause the driver or passenger to suffer complex nose injuries. The nose can be restored by creating a 3D model on a computer. At the same time, a biopsy of the patient is performed and cartilage cells are removed from the victim's body, such as from a knee, a finger, an ear, or fragments of a broken nose. The cells are spawned in the laboratory and mixed with the biopolymer. From this suspension, a model of nasal cartilage is created using a bioprinter, which is implanted into the patient during surgery. In the process, the biopolymer is used simply as a mold. It is subsequently broken down by the body's own cartilage cells. And in a couple of months it will be impossible to distinguish between the graft and the person’s own nasal cartilage.”
Since the implant was grown from the body's own cells, the risk of rejection will be much lower than for an implant made of, say, silicone. An additional advantage is that the bioimplant grows with the patient, which is especially important for children and young people.
If a person is severely burned, healthy skin can be taken from another part of the body and used to cover the affected area. Sometimes intact skin is missing.
Researchers at Wake Forest School of Medicine have successfully designed, built and tested a printer that can print skin cells directly onto a burn wound. The scanner very accurately determines the size and depth of damage. This information is sent to a printer and skin is printed to cover the wound. Unlike traditional skin grafts, it only takes a patch of skin one-tenth the size of a burn to grow enough cells to print. While this technology is still in the experimental stage, the researchers hope that it will be widely available within the next five years.
As already mentioned, 3D printers print products in layers, and since the skin is a multi-layered organ with different types of cells, it is well suited for this type of technology. However, researchers still have a lot of problems to solve, in particular, how to prevent damage to cells from the heat generated by the printer. And of course, like most parts of the human body, the skin is more complex than it first appears—there are nerve endings, blood vessels, and a host of other aspects to consider.
Biomechanical engineer Monica Moya holding a petri dish with printed alginate-based biotubes. Biotubes can act as temporary blood vessels similar to blood vessels that help create a patch of living tissue.
With tens of thousands of miles of veins, arteries and capillaries in the human body, researchers are working to replace them if they ever wear out. The creation of viable blood vessels is also essential for the proper functioning of all other potential bioprinted body parts.
Biomechanical Engineer Monica Moya of Livermore National Laboratory. Lawrence uses bioprinting to create blood vessels. The materials created by her bioprinters are engineered to allow small blood vessels to develop on their own.
This development takes time, so vials of cells and other biomaterials are printed to help deliver vital nutrients to the printed environment. After a while, self-assembled capillaries connect with bioprinted tubes and begin to deliver nutrients to cells on their own, mimicking the work of these structures in the human body.
Many researchers hope that in 20 years the lists of patients waiting for organ transplants will become a thing of the past. They envision a world where any organ can be printed and transplanted in just a few hours, without rejection or complications, because these organs will be created from body cells according to the individual characteristics of each patient. Currently, bioprinting of fully functional complex internal organs is not possible, but research is ongoing (and not without success).
For example, the bladder is already printed. In 2013, at Wake Forest University in the US, researchers successfully took cells from a patient's original, poorly functioning bladder, cultured them, and added additional nutrients. The 3D shape of the patient's bladder was then printed and the cultured cells soaked through it. The form was placed in an incubator and, when it reached the desired condition, it was transplanted into the patient's body. The mold will eventually collapse, leaving only the organic material. The same team successfully created viable urethras.
Physicians and scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) were the first in the world to create laboratory-grown organs and tissues that were successfully transplanted into humans. Right now they are working on growing tissues and organs for more than 30 different areas of the body, from the kidneys and trachea to cartilage and lungs. They also aim to accelerate the availability of these treatments to patients.
Scientists in Australia are doing similar research as well. They used human stem cells to grow a kidney organ that contains all the necessary cell types for a kidney. Such cells can serve as a valuable initial source for bioprinting more complex kidney structures.
MD, Professor of Urology, Professor of the Institute of Regenerative Medicine Anthony Atala shows a kidney created by a bioprinter. A modified desktop inkjet printer sprays cells instead of ink. The cells were cultured from the patient and the structural template for the kidney was obtained from the MRI (so it is the correct size and shape).
Using this technology, back in 2001, Atala printed and successfully transplanted a bladder into a young man, Jake.
Heart cells, laboratory-grown organelles. Source
Surprisingly, it is the human heart that can become one of the easiest organs to print, since, in fact, it is a pump with tubes. Of course, everything is not so simple, but many researchers believe that humanity will learn to print hearts before kidneys or liver.
Researchers at the Wake Forest Institute for Regenerative Medicine in April 2015 created "organoids" - 3D printed fully functional, beating heart cells.
In April 2019, Israeli scientists printed the world's first 3D heart. It is still very small, the size of a cherry, but it is able to perform its functions. The 3D heart with blood vessels uses personalized "ink" of collagen, a protein that supports cell structures, and other biological molecules.
A Tel Aviv University researcher holds the world's first 3D printed heart on April 15, 2019.
“This is the first time anyone anywhere has successfully designed and printed a whole heart with cells, blood vessels, ventricles and chambers,” said Tel Aviv University scientist Professor Tal Dvir.
So far, scientists have been able to print tissue from cartilage and the aortic valve, for example, but the challenge has been to create tissue with vascularity—the blood vessels, including capillaries, without which organs cannot survive, let alone function.
The Tel Aviv scientists started with human adipose tissue and separated the cellular and non-cellular components. They then reprogrammed the cells to become undifferentiated stem cells, which could then become cardiac or endothelial. Endothelium - a single layer of flat cells lining the inner surface of the heart cavities, blood and lymphatic vessels. Endothelial cells perform many functions of the vascular system, such as controlling blood pressure, regulating the components of blood clotting, and the formation of new blood vessels.
Non-cellular materials, including a large amount of proteins, were processed into a "personalized hydrogel" that served as "printing ink".
It will be years before this technology can create organs for efficient transplantation. However, the achievements of scientists in Tel Aviv are a huge milestone along the way.
Medical research and pharmacology
One of the key potential uses for bioprinted living materials is in the field of medical and drug research. Bioprinted tissues have several cell types with different densities and key architectural features. This allows researchers to study the impact of various diseases on the body, the stages of disease progression and possible treatments in the natural microenvironment.
One of the most impressive developments in recent years is the development of a desktop brain at the ARC Center of Excellence in 2016. The researchers were able to use a 3D printer to create a 3D printed six-layer structure that includes nerve cells that mimic the structure of brain tissue.
This opens up huge potential benefits for researchers, pharmaceuticals and private companies, because it will allow them to test new products and drugs on tissue that accurately reflects the responses of human brain tissue, as opposed to animal samples, which may cause a completely different response. The desktop brain can also be used to further investigate diseases such as schizophrenia or Alzheimer's.
We are far from printing the brain, but the ability to arrange cells to form neural networks is a significant step forward. By allowing researchers to work with human tissue in real time, testing processes can be greatly accelerated and results can be more realistic and accurate. It will also reduce the need to use laboratory animals for medical tests and potentially dangerous human testing.
Medical simulators and data registries
About 3,000 medical simulators are currently in use around the world to help doctors practice complex procedures. Virtual blood vessels, 3D printed organs... and no animal suffers!
The American company 3D Systems created an industry segment called VSP (Virtual Surgical Planning). This approach to personalized surgery combines expertise in medical imaging, surgical simulation and 3D printing. Surgeons using the Simbionix medical simulator for the first time often report feeling physical pain while empathizing with their virtual patient - the experience is so realistic. Organs and tissues look completely real. When stitching an organ, the surgeon sees on the screen a needle that enters the tissue, and pulls the thread. If the doctor does something wrong, the virtual blood vessels break and the organ begins to bleed. These simulators were developed by the Israeli company Symbionix, which was acquired by 3D Systems in 2014.
On September 3, 2019, the Radiology Society of North America (RSNA) and the American College of Radiology (ACR) announced the launch of a new 3D Medical Printing Clinical Data Registry to collect data on treatment outcomes using 3D printing at the point of care. This information will be a powerful tool to assess and improve patient care in real time, drive ongoing research and development, and inform patients and healthcare professionals about the best course of care.
“The creation of a joint RSNA-ACR 3D printing registry is essential to the advancement of clinical 3D printing. The registry will collect data to support the appropriate use of this technology and its implications for clinical decision making. ”
William Widock, Professor of Radiology at the University of Michigan and Chairman of the RSNA 3D Printing Special Interest Group (SIG)
According to the RSNA, the information in the registry will allow for the necessary analysis to demonstrate the clinical value of 3D printing. Due to the wide variety of clinical indications, different technologies for creating physical models from medical images, and the complexity of the models, it is problematic to choose the optimal treatment method. The registry will help solve this problem.
Bioprinter and bioprinting software manufacturer Allevi introduced Allevi Bioprint Pro software on September 5, 2019. Built-in model generation and integrated slicing will allow you to focus more on experimenting, rather than setting up the printer. The program runs entirely in the cloud, which means you can create your biostructures, define materials, and track prints right from a web browser on any computer.
According to the development team, the new bioprinter with the above software is powerful and easy to use and represents another piece of the puzzle on the way to 3D printed organs.
At the same time, CELLINK, the first bio-ink company, announced the launch of a new product to become the most flexible bio-printing platform on the market. The BIO X6 bioprinter, which has no analogues at the moment, has the ability to combine more bioprinting materials, cells and tools.
Why is this taking so long?
Complex body structure
The human body and its various components are much more complex than a plastic toy. The human organ has a complex network of cells, tissues, nerves, and structures that must be arranged in specific ways to function properly. From placing thousands of tiny capillaries in the liver to actually getting a printed heart that "beats" and contracts in the human body, there is still a lot of research and testing.
In addition, bioprinting technologies, like all new medical treatments, must pass safety tests and due process of regulation before they become available.
Special software and hardware
It also takes time to develop special software and hardware. These programs can be written only with the appropriate data (medical, clinical, statistical, mathematical, and so on), which someone must first collect, analyze, systematize and digitize.
Working through all of these steps requires the integration of technologies from various fields, including engineering, biomaterials science, cell biology, physics, mathematics, and medicine. So we need to be a little more patient.
The main thing is to know that those who work in the field, doctors and engineers, programmers and scientists are making progress every day both in bioprinting technology itself and in understanding how it can be used and improved. Although we are not quite there yet, there is no doubt that medicine will be very different in 10-20 years, thanks also to bioprinting.
Bioprinting is an extension of traditional 3D printing.
Bioprinting can produce living tissue, bones, blood vessels, and possibly entire organs for use in medical procedures, medical training, and testing.
The cellular complexity of a living organism has made 3D bioprinting slower to develop than conventional 3D printing.
Bioprinting technology could enable the generation of patient-specific tissues to develop precise, targeted and fully personalized treatments.
We still have a long way to go before we can create fully functioning and viable organs for human transplantation.
Related materials: Russia was the first in the world to print living tissues in space using a bioprinter
5 most amazing things created using 3D printingA rocket printed on a 3D printer
will go into orbit in 2021 "Exhibits touching is allowed”: how 3D printing is transforming museums
© Rusbase, 2019
Author: Nadezhda Aleinik
Cover photo: etonastenka, Depositphotos
Bioprinter: printing organs on a 3d printer
3D bioprinting is an advanced technology that saves lives and helps create new medicines. What is the peculiarity and complexity of developments, who is engaged in them and what successes have already been made - this will be discussed in the material. We will also get acquainted with all the methods of bioprinting known today.
- How bioprinters print and what is 3D bioprinting
- What is printed on 3D bioprinters?
- Where do they print?
- 3D bioprinters in Russia
How bioprinters print and what is 3D bioprinting
3D bioprinting is the creation of 3D models using biomaterial, which includes living cells. It is used to reproduce complex structures such as skin tissue or blood vessels.
Cells to create a model are taken from the patient and cultured until their mass is sufficient to create a bioink. The resulting ink is loaded into the printer, which prints the desired model.
Getting enough cells is not always possible, so seaweed or porcine collagen protein comes to the rescue. Stem cells are also used, which have the ability to become any cell in the body.
The first biological 3D printer
The first serial bioprinter was released by the American company Organovo by the end of 2009. The Australian company Invetech became its industrial partner. Thanks to joint efforts, the machine was born, which in 2010 printed the first full-fledged blood vessel.
Organovo representatives decided to move away from the idea of growing organs in a test tube and suggested that it would be much more efficient to print it. They came up with the NovoGen technology, which regulated all the interactions between the biological component of the process and its mechanical part. Invetech was involved to implement the idea. The collaboration resulted in a compact device with an intuitive interface.
The printer had two printheads. One was filled with the necessary biomaterial, the second - with auxiliary components (collagen supporting the hydrogel, growth factors). Printing accuracy reached micrometers, which played an important role in the correct placement of cells.
3D bioprinting technologies
There are several technologies and approaches being developed and applied in the field of bioprinting. Scientists and researchers from private companies and institutions work on each of them.
Multimaterial Multinozzle 3D (MM3D) technology, Wyss Institute
The technology developed at the institute is based on the use of fast moving high pressure valves. The applied method makes it possible to switch between materials up to 50 times per second. This speed is faster than you can see with the naked eye.
The printheads themselves are 3D printed, so they can be easily customized to your specific needs.
The technology is suitable for the manufacture of complex objects, including mobile robots. The method significantly speeds up the creation of complex models, because the printheads can use several nozzles at once.
Sound-Induced Morphogenesis (SIM) Technology by mimiX Biotherapeutics
Swiss technology is based on the reproduction of well-defined biological patterns that self-assemble into functional tissues using sound waves. The method embodies a highly efficient sequence for reproducing organized and dense cellular structures.
The mimiX technology uses sound waves. The space for growing cells is formed around a given type of speaker. Depending on the shape of the cup and the sound produced, structures of various shapes, such as gratings, are formed.
The creation of this method serves an important purpose - the availability and speed of playback that can be achieved in any room. Prior to the invention of the SIM, bioprinting was available for scientific research. For clinical, it has become too complicated and lengthy. Now this has changed.
Fluicell Biopixlar Bioprinter
Swedish-based Fluicell focuses on creating platforms for studying cell behavior. Her method of work makes it possible to make complex structures that mimic tissue, in which the location of individual cells is controlled by a gamepad. The workflow is similar to a video game.
The company uses the micro-jet technique. Thanks to the micro jet tube and the precision of the pump during the direction of the biomaterial to the printing zone, it gives micro-level control over the material. Because of this, systems scale to the macro level naturally. High resolution prints are produced.
The method makes it possible to reproduce multicomponent structures, while the material can be created in the printer itself. This approach eliminates the need for laboratory preparation. The mixing progress of different materials is controlled in the microfluidic chamber. The result is a 3D printed finished structure, which was created without the use of gels and scaffolds.
The technical capabilities of this method make it ideal for processing scarce materials such as biopsy specimens, stem cells and primary cells.
CELLINK is a Swedish company that develops bioprinting technologies for various applications, including cosmetics and medicine. The principles generated by the organization work to create skin tissue, cartilage, liver and other products.
In 2019, the manufacturer launched two models of bioprinters on the market - Bio X6 and Lumen X. The first one is designed for creating constructs with any type of cells. With it, you can reproduce any tissue found in the body. The company focuses on quick results and combining a large number of materials.
The Bio X6 has 6 printheads built in with CELLINK Clean Camera Technology. It is equipped with a smart interchangeable head method and two powerful fans to create excess air pressure inside the chamber. The user gets the opportunity to combine several materials in one print with a structure of increased complexity.
The second Lumen X unit is the result of a collaboration with the American company Volumetric. This is a startup focused on creating bioprinters using SLA technology. The device has a low cost and modest dimensions. At the same time, it has high printing accuracy and excellent performance. Such characteristics are especially important for the creation of vascular structures. Lumen X gets the job done 10 times faster than its competitors under the same conditions.
Bioprinter for Microtia patients creating human ears, University of Wollongong
Myctoria is a congenital defect associated with developmental arrest of the outer ear. It is found during pregnancy. Since the structure of the ear has a specific shape, the treatment of its deformity causes serious difficulties. According to the creators of the bioprinter, the new technology is leading to a revolution in helping children with microtia.
The Australian University of Wollongong created the Alek 3D printer. It prints human ears for further use in reconstructive surgery. Stem cells serve as the basis for bioink. The creation of ears on a bioprinter looks very promising, since the method allows you to design a transplant according to the shape of the patient's face and do it in a fairly short time. The technology excludes the search for donors to take a piece of cartilage, the work is based on the use of the patient's natural tissues.
Manufacturers are engaged not only in the development of technology and design of printing devices, but also in materials that can be used to create complex structures and entire organs.
Allevi Liver Tissue Ink
The complexity of reproducing the liver lies in the fact that it has many important functions for life. There are more than five hundred of them. A small number of manufacturers are able to create bio-ink for the liver that will meet all the necessary conditions.
The American company Allevi is one such company. The drug, which makes it possible to reproduce tissue-like structures that mimic the natural characteristics of tissues, can be freely purchased through the Allevi online store.
Biogelx Synthetic Bioink
Biogelx is a company from Scotland. It is based in a laboratory at the University of Strathclyde in Glasgow. The direction of the company is the research and creation of artificial materials for bioprinting.
Hydrogel ink has a unique chemical and physical variability. It allows you to accurately recreate a variety of tissue parameters. As a result, cells are able to interact in an almost natural environment.
Ink helps keep cells alive. They provide a simple crosslinking technique and viscosity control as well as a high degree of reproducibility. Due to its positive technical abilities, the material is compatible with a wide range of 3D bioprinters.
Hydrogel with mineral nanoparticles, University of Texas
American development from the staff of the University of Texas (TAMU). Scientists have created a material in the form of a hydrogel. It contains mineral nanoparticles. They have the ability to carry out protein preparations to control the behavior of cells. Inks of this kind help in the field of creating tissues containing blood vessels.
Developers have been developing hydrogel bioinks based on the inert polymer PEG (polyethylene glycol). Printing with this type of ink is difficult due to its low viscosity. In the course of research, it turned out that silicate nanoparticles effectively increase the degree of viscosity, while almost not changing the other technical parameters of the printed material. Thus, TAMU workers have created a new class of hydrogels.
Bio-ink for artificial leather printing, Renseller Polytechnic Institute
The production of high-quality imitation skin after burns and other wounds has been on the minds of bioengineers for many years. There are 2 ways to treat serious skin lesions. The first is the use of autologous skin grafts. Healthy tissue is taken from the patient and transplanted to damaged areas, while fresh wounds are formed and, in general, the procedure is quite unpleasant and painful.
The second method is to use skin substitutes made from foreign materials, such as bovine collagen. Such imitations do not completely cover deep wounds and are very different from natural skin.
Skin resurfacing technology from a collaboration between Rensselaer Polytechnic Institute (RPI) and Yale University promises to revolutionize skin grafting. They created bio-ink using living human cells. The material helps in reproducing artificial skin, which later itself recreates the system of blood vessels.
3D Bioprinting Solutions
3D Bioprinting Solutions is the only organization in Russia dealing with bioprinting. The company was founded in 2013. One of the co-founders was the co-founder of INVITRO - Alexander Ostrovsky. His specialty is a resuscitator.
In 2014, the laboratory presented the first bioprinter made in Russia. He received the name FABION. According to the list of the use of various printed materials, this device is one of the leaders in the field of multifunctional devices.
In early 2015, the company created and successfully transplanted a mouse thyroid organ construct. In 2016, researchers produced a printhead that can automatically feed tissue spheroids for 3D bioprinting. The development was applied in the new version of the device - FABION-2.
After the release of an updated version of the device, the company's specialists focused on creating a printer that uses a new working methodology, different from previous solutions. It was the principle of magnetic levitation and the ability of microtissues to self-assemble from tissue spheroids. A fully functioning magnetic assembly saw the light of day by the spring of 2017.
At the end of the summer of 2017, cooperation with the state company Roscosmos began. The laboratory has signed a contract for the implementation of a space biofabrication experiment aboard the Russian part of the ISS. Scientists have begun to develop the Organ.Avt printer capable of working in zero gravity.
The Magnetic Bioprinter experiment started at the end of 2018. In its course, models of human bone and cartilage tissue, as well as the mouse thyroid gland, were printed. To carry out the work, the Soyuz MS-11 crew members underwent appropriate training at the 3D Bioprinting Solutions laboratory.
In addition to bioprinters, the company has developed a line of multifunctional collagen products - Wiscoll. It is suitable for use in any 3D bioprinter. Bioink is used for a wide range of biofabrication experiments. The product is a concentrated solution of collagen of the first type of the highest degree of purification. It is immediately ready for use.
What is printed on 3D bioprinters?
Printing fully functional complex internal organs is not yet possible, although research is ongoing in this area. For example, the bladder has already managed to reproduce. It happened in 2013 in the USA (Wake Forest University).
Scientists have extracted raw material from a patient's poorly functioning organ, nurtured them and added nutrients. Next, they reproduced the shape of the bladder according to the parameters of the patient and cultured cells impregnated through it. The model was placed in an incubator, brought to the required condition and transplanted into a human. Over time, it collapsed, leaving completely organic material in its place.
The same team produced viable urethras. Research is ongoing and breakthroughs are being made in the creation of the kidneys, liver and heart.
Printing of tissues and vessels
The human body is pierced by tens of thousands of kilometers of capillaries, arteries and veins. Over time, they wear out, and scientists are conducting research on the possibility of their full replacement. Creating body parts on a bioprinter is impossible without reproducing viable blood vessels. Technologies make it possible to create materials designed for further favorable independent development of blood vessels.
Surgeons got the opportunity to practice on operations on organs and tissues that look 100% real. This happens both with the help of virtual prototyping and with the use of 3D printed models.
New drug testing
Bioprinted tissue has multiple cell types with different densities and key architectural features. This makes it possible to conduct research on the impact of diseases on the body, as well as to work out various methods of treatment.
Where do they print?
Organizations that offer organ printing or sell bioprinters:
- 3D Bioprinting Solutions - Russia, Moscow. Specializes in frameless printing, created two printers - FABION and FABION-2. Develops his own method of organoprinting.
- Organovo - USA, San Diego. Produces and sells liver tissue to pharmaceutical companies. In 2009, the first mass-produced bioprinter, Novogen, was released.
- BioBots - USA, Louisville. A startup that introduced a cheap bioprinter for commercial use in 2013. Available BioBot BASIC. Work is underway on the second version of the device.
- Cyfuse Biomedical - Japan, Tokyo. The company produced the Regenovo bioprinter, which can be used to create skin tissues and grow blood vessels.
3D bioprinters in Russia
So far, bioprinting devices in Russia are represented by only one company created by the co-founder of the INVITRO network - 3D Bioprinting Solutions. Ongoing research on the Russian part of MSCs under weightless conditions gives researchers hope that unique data will be obtained, on the basis of which new drugs will be developed.
Scientists are also optimistic about the creation of functional complex organs of the human body, saying that they will appear already in the current century.
Emerging technologies in the field of bioprinting make it possible to draw the following conclusions: